Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

13%

1 trials in Phase 3/4

Results Transparency

100%

7 of 7 completed trials have results

Key Signals

1 recruiting7 with results

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 4

1(20.0%)

5Total

N/A(4)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT06539715Phase 4Completed

Comparison of Visual Field Assessments Between Three Perimeters

Role: lead

NCT06122103Completed

Comparison of Visual Outcomes With Mini-Monovision Between a Monofocal and an Adjustable Intraocular Lens

Role: lead

NCT07325188Not ApplicableRecruiting

HUD Surgical Guidance for Toric Alignment

Role: lead

NCT04936256Completed

Evaluation of Binocular Visual Acuity and Refractive Stability in the Alcon Clareon Intraocular Lens

Role: lead

NCT04126187Completed

AcrySof® Bilateral PanOptix(R) Spectacle Freedom and Patient Satisfaction Study

Role: lead

NCT04126174Not ApplicableCompleted

Femtosecond Laser-assisted Arcuate Incisions Versus Manual Arcuate Incisions Outcomes

Role: lead

NCT03856944Not ApplicableCompleted

Evaluating Refractive and Visual Outcomes With the Alcon Toric ReSTOR +2.5 and +3.0 Models

Role: lead

NCT02763124Not ApplicableCompleted

Pseudophakic Astigmatic Reduction With Verion-LenSx Arcuate Incisions

Role: lead

All 8 trials loaded